Goodrx Holdings 

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$198,583
$195,251
$200,610
$197,880
Gross Profit
186,390
183,567
171,775
169,470
EBITDA
41,863
38,002
36,843
36,323
EBIT
22,767
20,467
19,878
20,381
Net Income
6,740
12,259
6,694
-1,008
Net Change In Cash
198,583
195,251
200,610
197,880
Free Cash Flow
28,099
71,003
-7,528
21,971
Cash
448,346
423,777
524,903
533,294
Basic Shares
383,576
388,504
384,732
390,048

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$792,324
$750,265
$766,554
$745,424
Gross Profit
744,109
683,340
701,475
698,708
EBITDA
153,920
108,824
68,538
48,004
EBIT
84,382
1,156
11,012
10,363
Net Income
16,390
-8,868
-32,828
-25,254
Net Change In Cash
792,324
750,265
766,554
745,424
Cost of Revenue
-183,944
-30,482
Free Cash Flow
163
82,526
91,566
144,322
Cash
448,346
672,296
757,165
941,109
Basic Shares
392,172
410,315
412,858
400,562

Earnings Calls

Quarter EPS
2024-12-31
$0.09
2024-09-30
$0.08
2024-06-30
$0.08
2024-03-31
$0.08